ANNA RICHO

CIK 1199306 · SVP & CCO · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$19.93M

Companies

4

Total Filings

51

Lifetime Open-Market Net

-$8.53M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ILMN Director 8,527 $160.97 $1.37M $0 3 2026-05-22
EXCw Director 11,337 $0 12 2026-04-29
Adamas Pharmaceuticals Inc (ADMS) Delisted Director 0 $8.22 $0 $0 3 2021-11-24
AMGN SVP & CCO 52,248 $355.20 $18.56M -$8.53M 33 2012-08-01

Recent Filings · Page 2 of 6

51 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-07-02 EXCw Grant (A) +1,161 $41.3K EDGAR
2024-05-22 ILMN Grant (A) +2,622 $0 EDGAR
2024-04-02 EXCw Grant (A) +1,131 $41.3K EDGAR
2024-01-02 EXCw Grant (A) +1,052 $41.2K EDGAR
2023-10-02 EXCw Grant (A) +674 $27.4K EDGAR
2021-11-24 Adamas Pharmaceuticals Inc (ADMS) Delisted Mixed −25,000 $0 EDGAR
2021-06-04 Adamas Pharmaceuticals Inc (ADMS) Delisted Grant (A) +5,000 $0 EDGAR
2020-09-01 Adamas Pharmaceuticals Inc (ADMS) Delisted Grant (A) +10,000 $0 EDGAR
2012-08-01 AMGN Mixed -$104.7K EDGAR
2012-07-31 AMGN Mixed -$78.2K EDGAR
Showing 1120 of 51
Page 2 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.